MDPI and ACS Style
Hsu, F.-S.; Wu, J.-T.; Lin, J.-Y.; Yang, S.-P.; Kuo, K.-L.; Lin, W.-C.; Shi, C.-S.; Chow, P.-M.; Liao, S.-M.; Pan, C.-I.;
et al. Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway. Int. J. Mol. Sci. 2019, 20, 1162.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20051162
AMA Style
Hsu F-S, Wu J-T, Lin J-Y, Yang S-P, Kuo K-L, Lin W-C, Shi C-S, Chow P-M, Liao S-M, Pan C-I,
et al. Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway. International Journal of Molecular Sciences. 2019; 20(5):1162.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20051162
Chicago/Turabian Style
Hsu, Fu-Shun, June-Tai Wu, Jing-Yi Lin, Shao-Ping Yang, Kuan-Lin Kuo, Wei-Chou Lin, Chung-Sheng Shi, Po-Ming Chow, Shih-Ming Liao, Chun-I Pan,
and et al. 2019. "Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway" International Journal of Molecular Sciences 20, no. 5: 1162.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20051162